Latest Trials
| EudraCT Number: 2004-000632-82 | Sponsor Protocol Number: AC-052-333 | Start Date: 2004-09-16 | ||||||
| Sponsor Name: Actelion Pharmaceuticals Ltd. | ||||||||
| Full Title: Long term bosentan open label extension of the RAPIDS-2 study in Systemic Sclerosis patients with ischemic digital ulcers | ||||||||
| Medical condition: SSc is a multi-system disorder of unknown etiology characterized by fibrosis and vascular obliteration in the skin and visceral organs. The pathogenesis of SSc involves immunologic mechanisms vascu... | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: GB (Completed) IT (Completed) | ||||||||
| Trial results: View results | ||||||||